105 studies found for:    Melanoma (women OR woman OR female)
Show Display Options
RSS Create an RSS feed from your search for:
Melanoma (women OR woman OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
Condition: Melanoma
Intervention: Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided
2 Active, not recruiting Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass
Conditions: Breast Cancer;   Genitourinary Cancer;   Malignant Female Reproductive System Neoplasm;   Melanoma;   Sarcoma
Intervention: Procedure: Punch Biopsy
3 Completed Microarray Analysis for Human Genetic Disease
Conditions: Breast Neoplasm;   Hereditary Neoplastic Syndrome;   Melanoma;   Ovarian Neoplasm
Intervention:
4 Completed Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Lung Cancer;   Adult Soft Tissue Sarcoma;   Colorectal Cancer;   Bone Cancer;   Ovarian Sarcoma;   Melanoma;   Colon Cancer;   Rectal Cancer;   Breast Cancer;   Eye Cancer;   Uterine Sarcoma
Interventions: Drug: interleukin-2;   Drug: MAGE-12 peptide vaccine;   Drug: Montanide ISA-51
5 Completed
Has Results
Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study
Condition: Metastatic Malignant Melanoma
Interventions: Drug: Avastin;   Drug: Abraxane
6 Recruiting Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery
Condition: Melanoma (Skin)
Interventions: Drug: dasatinib;   Other: laboratory biomarker analysis
7 Recruiting Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
Conditions: Recurrent Melanoma;   Stage IIIB Melanoma;   Stage IIIC Melanoma;   Stage IV Melanoma
Interventions: Biological: ipilimumab;   Biological: recombinant interferon alfa-2b;   Other: quality-of-life assessment
8 Recruiting Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery
Conditions: Recurrent Melanoma;   Stage IIIC Melanoma;   Stage IV Melanoma
Interventions: Biological: bevacizumab;   Biological: ipilimumab;   Other: laboratory biomarker analysis
9 Unknown  Peptide Vaccination Associated With Tumoral Immunomodulation in Patients With Advanced Metastatic Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: Vaccine MAGE-3.A1 peptide, or the NA17.A2 peptide + IL-2, IFN-α and GMCSF, Imiquimod.
10 Completed
Has Results
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
Conditions: Melanoma;   Metastases
Interventions: Drug: MDX-010 (anti-CTLA4) monoclonal antibody;   Biological: MDX-1379 (gp100) Melanoma Peptide Vaccine
11 Recruiting Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma
Condition: Metastatic Melanoma
Intervention: Radiation: WBRT
12 Completed SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
Condition: Melanoma (Skin)
Intervention: Procedure: Surgery
13 Terminated Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma
Condition: Melanoma
Intervention:
14 Recruiting A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Condition: Melanoma
Interventions: Biological: Poly-ICLC;   Biological: Peptides
15 Recruiting Neurotropic Melanoma of the Head and Neck
Condition: Neurotropic Melanoma of the Head and Neck
Interventions: Other: Observation;   Radiation: Radiation Therapy
16 Recruiting Dendritic Cell Activating Scaffold in Melanoma
Condition: Melanoma
Intervention: Biological: WDVAX
17 Completed Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
Condition: Melanoma (Skin)
Interventions: Genetic: comparative genomic hybridization;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Other: immunohistochemistry staining method
18 Recruiting Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size;   Ciliary Body and Choroid Melanoma, Small Size;   Iris Melanoma;   Metastatic Intraocular Melanoma;   Recurrent Intraocular Melanoma;   Stage IIIA Intraocular Melanoma;   Stage IIIB Intraocular Melanoma;   Stage IIIC Intraocular Melanoma;   Stage IV Intraocular Melanoma
Interventions: Drug: cabozantinib-s-malate;   Drug: temozolomide;   Drug: dacarbazine;   Other: laboratory biomarker analysis
19 Completed The Incidence of Breast and Other Cancers Among Female Flight Attendants
Conditions: Thyroid Cancer;   Breast Cancer;   Non-Melanoma Skin Cancer;   Melanoma
Intervention:
20 Recruiting Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
Conditions: Recurrent Melanoma;   Stage IIIA Melanoma;   Stage IIIB Melanoma;   Stage IIIC Melanoma;   Stage IV Melanoma
Interventions: Biological: ipilimumab;   Biological: recombinant interferon alfa-2b;   Other: laboratory biomarker analysis

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years